Home
/
Treatment
/
(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile

(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile

	(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile
Trade Name
Orphan Indication	Dystrophic epidermolysis bullosa
USA Market Approval	USA
USA Designation Date	2017-01-05 00:00:00
Sponsor	Almirall, S.A.;Ctra. Laurea Miro, 408-410, Sant Feliu de Llobregat;Barcelona